CHINA-HI-TECH-FAIR
15.11.2023 19:07:32 CET | Business Wire | Press release
The 25th China Hi-Tech Fair (CHTF) commenced on November 15, 2023 in Shenzhen, China, featuring the theme "Invigorate the Power of Innovation, Upgrade the Quality of Development." The exhibition is expected to cover an area of 500,000 square meters, making it the most extensive and globally diverse session to date. Renowned guests from around the world will be gathered to explore trends in technological innovation and future directions, collectively contributing to the implementation of innovation-driven development strategies. The fair will run until November 19.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231115260072/en/
Highlights of the Event:
Diverse Exhibition Zones: CHTF in Futian District features specialized shows including the National Innovation & Tech Show, International Innovation & Tech Show, Investment & Consulting Services, Specialized and Sophisticated SMEs, Next Generation IT, Environmental Protection, New Display, Smart City, Digital Healthcare, and High-end Equipment Manufacturing. The exhibition area in Bao'an District complements this with exhibitions on Clean Energy, New Materials, Aerospace Technology, Emergency Safety Technology, Green & Low-Carbon, and Scientific Experimental Instrument.
Government and Academic Participation: Five Chinese ministries including the Ministry of Commerce and the Ministry of Industry and Information Technology, along with 33 provinces and cities, and 27 prestigious universities such as Tsinghua University and Peking University, will participate. Key enterprises including state-owned companies like Sinopec and PetroChina, industry leaders like Huawei and ZTE, and innovative SMEs like Gecko Motors and Corerain are among the exhibitors.
Global Recognition: CHTF has attracted widespread attention from the global tech community, with over 105 countries and regions participating. Notable international organizations and companies, including Intel and Starbucks, will unveil major projects during the fair.
Belt and Road Initiative Focus: Celebrating the 10th anniversary of the Belt and Road Initiative (BRI), this year's CHTF will serve as a new opportunity for scientific and technological innovation cooperation among BRI countries, contributing to the high-quality development of the initiative.
International Representation: Countries along the Belt and Road, including the UAE, Kenya, Poland, Russia, Serbia, Greece, and Hungary, are sending delegations led by ministerial-level officials, setting up national pavilions to showcase the latest technologies and products, and hosting investment-oriented roadshows. Several pavilions, including those of Pakistan and Hungary, are organizing themed activities.
The 25th CHTF promises to be a milestone event, fostering global collaboration, and advancing technology for a sustainable future.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231115260072/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Egon Zehnder Names Ayşe Güçlü Onur Global Human Resources Practice Leader2.9.2026 15:00:00 CEST | Press release
Egon Zehnder has appointed Ayşe Güçlü Onur as Global Leader of its Human Resources Practice. This appointment comes as companies and boards increasingly look to CHROs to help shape business strategy, lead transformation, build leadership pipelines, and navigate major shifts in culture and the workforce. "CHROs used to be evaluated by how well they supported the business. Today, the best drive it," said Onur. "Our role is to help CHROs move from a seat at the table to a hand in business growth. We help them connect leadership decisions, talent, and culture directly to elevated performance. That's the shift Egon Zehnder is built to guide with our leadership advisory services." Egon Zehnder’s Human Resources Practice partners with companies to discover, develop, and transform future-ready CHROs, helping them shape the future of the function. This includes executive search, leadership assessment and development, board effectiveness, culture, succession planning, organizational transformati
Safe Software to Increase Global Headcount by Over 15% as Demand for AI-Ready Data Grows2.9.2026 15:00:00 CEST | Press release
The FME creator is recruiting for more than 60 roles across the UK, US and Canada before the end of December, less than a year after crossing $100M in revenue Safe Software, the creator of FME, the only All-Data, Any-AI enterprise integration platform with true support for spatial data, today announced it is recruiting for more than 60 roles throughout the remainder of 2026. The hiring will take the company past 400 employees, increasing headcount by over 15%, with new positions across the United Kingdom, the United States and Canada. The expansion follows a year in which Safe crossed $100 million in annual revenue, growing close to 20 percent year over year and moving ahead of schedule on its target of $250 million by 2028. The company also grew its employee base by over 20% in the same period. "The incredible growth that we’ve seen over the last 30+ years at Safe has always been a testament to the great people behind what we do," said Don Murray, Co-Founder and CEO of Safe Software.
Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Datato Boehringer Ingelheim2.9.2026 14:00:00 CEST | Press release
Owkin, the agentic AI company striving to transform drug discovery and development for biopharma, today announced a license agreement with Boehringer Ingelheim for K Pro, Owkin’s AI Scientist, together with multimodal patient data, aiming to speed up the discovery process across multiple indications in oncology and immunology. This agreement builds upon an initial pilot undertaken by Owkin with Boehringer in 2025. In that pilot Owkin delivered deep spatial insights into the tumor microenvironment of a gene target through its MOSAIC dataset. Under the new agreement, Owkin will license multimodal oncology data to Boehringer and will generate new multimodal data in immunology. Owkin licenses, sources and generates multimodal patient data in collaboration with its global patient data network. Boehringer Ingelheim’s teams will access and analyze this data through K Pro, which provides a single environment to interrogate data and run reproducible analyses. K Pro’s reasoning capabilities supp
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience2.9.2026 14:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. The licensed VHH antibody molecule was generated from Biocytogen’s proprietary RenNano® platform. The RenNano® platform is designed to discover fully human VHH antibody molecules with favorable specificity, binding affinity, and developability, and can generate molecular building blocks for the design and development of VHH antibodies, bispecific/multispecific antibodies, antibody-drug conjugates, and other innovative modalities. Through this license, Qilu Pharmaceutical may advance the research and development o
Croma-Pharma Introduces Electronic Instructions for Use Across the saypha® Portfolio2.9.2026 13:37:00 CEST | Press release
Healthcare professionals in eligible markets can now access the Instructions for Use for the saypha® portfolio digitally by scanning a QR code on the product packaging Croma-Pharma has introduced electronic Instructions for Use (eIFU) across its saypha® portfolio in markets where applicable regulations permit electronic Instructions for Use to replace printed versions. The transition expands digital access to essential product information for healthcare professionals while reducing the use of printed documentation. Healthcare professionals can access the current approved Instructions for Use by scanning the QR code on the saypha® folding box. The eIFU platform provides direct digital access to the latest approved Instructions for Use. "Innovation extends beyond product development. It also includes how we provide healthcare professionals with access to essential product information," said Andreas Prinz, Chief Executive Officer of Croma-Pharma. "The introduction of electronic Instructio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom